Search results
Agios (AGIO) Up 21% on Upbeat Data From 2nd Thalassemia Study
Zacks via Yahoo News· 1 month agoData from a late-stage study shows that transfusion-dependent thalassemia patients who received...
Bristol Myers (BMY) Gets EU Nod for Anemia Drug Reblozyl
Zacks via Yahoo News· 1 year agoBristol Myers Squibb (BMY) gets full marketing authorization from the European Commission, for...
bluebird's (BLUE) Gene Therapy Gets FDA Nod for Beta-Thalassemia
Zacks via Yahoo News· 2 years agobluebird bio BLUE recently announced that the FDA has approved Zynteglo (betibeglogene autotemcel),...
bluebird (BLUE) Up on Positive Data on Gene Therapies at ASH
Zacks via Yahoo News· 2 years agoShares of bluebird bio, Inc. BLUE gained 7.74% on Dec 12 after the company announced new and updated...
World-first gene therapy for inherited blood disorders approved in UK
PA Media: Science via Yahoo News· 8 months agoThe UK’s medicines regulator has authorised a world-first gene therapy as a potential cure for two...
Vertex (VRTX), CRSP's Casgevy Gets FDA Nod for Thalassemia
Zacks via Yahoo News· 6 months agoThis is the second approval granted to Vertex (VRTX)/CRISPR's (CRSP) gene therapy Casgevy and comes...
Vertex (VRTX) Rises 16.5% YTD: Time to Bet On the Stock?
Zacks via Yahoo News· 2 weeks agoVertex Pharmaceuticals Incorporated VRTX has been witnessing strong revenue growth, regulatory...
Editas (EDIT) Reports Upbeat New Data From Reni-Cel Studies
Zacks via Yahoo News· 3 weeks agoEditas (EDIT) reports positive new safety and efficacy data from the RUBY and EdiTHAL studies...
Geron (GERN) Wins FDA Approval for Blood Cancer Drug, Stock Up
Zacks via Yahoo News· 1 month agoGeron's (GERN) shares rise on approval of its first drug. The FDA approves imetelstat for the...
Agios (AGIO) Q1 Earnings Surpass, Sales Miss Estimates
Zacks via Yahoo News· 2 months agoAgios (AGIO) reports mixed earnings results for first-quarter 2024. Though sales miss the mark,...